◆ TICKERBASEVisão interativa →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Início › Todas as ações › 4901 · English version

FUJIFILM Holdings Corporation (4901)

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Industrials · Wall Street (EUA) · Última atualização: 2026-10-02

FUJIFILM Holdings Corporation provides products and services in the fields of healthcare, electronics, business innovation, and imaging in Japan, the Americas, Europe, Asia, and internationally. Its Healthcare segment offers products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment; equipment and materials for medical systems; drug discovery support, such as iPS cells; and cell culture media and reagents.

Números-chave

Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →

Demonstração de resultados anual

Demonstração de resultados2026-03-312025-03-312024-03-312023-03-312022-03-31
Receita totalJPY 3.36TJPY 3.20TJPY 2.96TJPY 2.86T—
Lucro brutoJPY 1.37TJPY 1.30TJPY 1.19TJPY 1.14T—
Resultado Operacional (EBIT)JPY 350.2BJPY 330.2BJPY 276.7BJPY 273.1B—
Resultado líquidoJPY 276.7BJPY 261.0BJPY 243.5BJPY 219.4B—

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de 4901. /companies/us/4901

Empresas semelhantes

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.